Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,030 public trials 2,565 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Not yet recruiting

Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)

NCT07260162

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Institut de Cancérologie de l'Ouest Saint-Herblain, Loire Atlantique, France

View Trial Details

Not yet recruiting

QLC5508 in Participants With Metastatic Prostate Cancer

NCT07632690

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

NCT07623642

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not yet recruiting

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

NCT07631884

Conditions: Advanced Malignant Solid Neoplasm, Biliary Tract Diseases, Biliary Tract Neoplasms, +56 more
Locations: Not specified

View Trial Details

Not yet recruiting

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

NCT07634094

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: UMPC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Not yet recruiting

An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

NCT07631871

Conditions: Adnexal Diseases, CERVICAL NEOPLASMS, Carcinoma, +38 more
Locations: Not specified

View Trial Details

Not yet recruiting

Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy

NCT07625137

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Langley Memorial Hospital Langley, British Columbia, Canada

Vancouver General Hospital (VGH) Vancouver, British Columbia, Canada

Hamilton Health Sciences Center Hamilton, Ontario, Canada

View Trial Details

Not yet recruiting

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

NCT07078838

Conditions: Body Weight, Endometrial Cancer, Endometrial Hyperplasia, +23 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Not yet recruiting

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

NCT07625527

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations: The Second Hospital of Tianjin Medical University Tianjin, China

General Hospital of Tianjin Medical University Tianjin, China

Tianjin Hospital Tianjin, China

Xingtai People's Hospital Xingtai, China

View Trial Details

Not yet recruiting

Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer

NCT07627620

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Not specified

View Trial Details

Urogenital Neoplasms

Urogenital Neoplasms trial results

Related conditions